Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 11,295 |
|
|||||
| News | (1) | ||||||
| Day High | 38.96 | Low High |
|||||
| Day Low | 38.70 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Halozyme Therapeutics Incorporated | HALO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.17 | 0.44% | 38.88 | 09:37:05 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 38.75 | 38.70 | 38.96 | 38.71 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 93 | 11,295 | $ 38.76 | $ 437,811 | - | 29.85 - 45.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:37:06 | 1 | $ 38.74 | USD |
Halozyme Therapeutics Incorporated Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.92B | 126.82M | - | 829.25M | 281.59M | 2.22 | 17.48 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Halozyme Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HALO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 38.35 | 39.27 | 37.73 | 38.33 | 790,550 | 0.53 | 1.38% |
| 1 Month | 40.57 | 41.60 | 37.73 | 39.59 | 885,391 | -1.69 | -4.17% |
| 3 Months | 34.26 | 42.64 | 33.15 | 38.74 | 1,047,257 | 4.62 | 13.49% |
| 6 Months | 35.00 | 42.82 | 32.83 | 37.58 | 1,170,636 | 3.88 | 11.09% |
| 1 Year | 34.27 | 45.00 | 29.85 | 37.45 | 1,096,459 | 4.61 | 13.45% |
| 3 Years | 49.67 | 59.46 | 29.85 | 41.15 | 1,101,114 | -10.79 | -21.72% |
| 5 Years | 16.09 | 59.46 | 12.71 | 34.75 | 1,197,794 | 22.79 | 141.64% |
Halozyme Therapeutics Description
| Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme utilizes a strategy that focuses on developing its own proprietary products in therapeutic areas with significant unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally. |
